Detail from the show Reflektor, Photo: Screenshot/TV Vijesti

Detail from the show Reflektor, Photo: Screenshot/TV Vijesti

Russia, Turkey and Belarus are introducing reciprocal measures against Montenegro as of November 1, which means that our citizens will need visas to travel to these countries, the Ministry of Foreign Affairs (MVP) confirmed last night in the Reflektor show on Television Vijesti.

These measures come after Montenegro’s decision to introduce visas for citizens of Russia, Turkey, China, Belarus and Saudi Arabia.

The visa will cost 35 euros, and it could take up to three months to be issued.

Montenegrin citizens will be able to travel to China without a visa by the end of the year, while a visa was required for Saudi Arabia earlier. The new measures could make travel particularly difficult for Montenegrin citizens who go to Turkey for treatment, diagnostics and medical therapies.

Ivana Đukanović from the MVP said in Reflektor that a note has also arrived stating that reciprocal measures will be introduced from November 1, and that they expect a note to arrive from Turkey as well.

“For China, by the end of the year, what we know is that the Chinese embassy has informed that Montenegrin citizens will be visa-free until the end of the year. However, we will make that announcement when it is all official, when we receive all the information,” said Đukanović.

When asked by the editor and host of the Reflektor show, Aleksandra Mudređa, whether this could also bring certain problems when we talk about our citizens, Bojan Bugarin, an expert in international law, answered in the affirmative.

“Regarding Montenegrin citizens traveling to Turkey, unfortunately I think that the largest number of them travel for health reasons. I don’t think that Montenegrin citizens are currently traveling in large numbers for tourist reasons. There are certainly some, but I think that unfortunately the most common reason for traveling to Turkey is precisely people who have to travel for health reasons, for treatment, for diagnostics, for various therapies. So I don’t know, we’ll see how this will specifically affect them,” Bugarin said.

Download the app and follow the news


FOLLOW US ON

News